Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
ASCO® 2023 Insights: "Epcoritamab + R² Regimen and Responses in High-Risk FL Regardless of POD24 Status"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Reid Merryman
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Reid Merryman
289 views
June 27, 2023
Comments 0
Login to view comments.
Click here to Login
Hematology